| Kristina Danielle Jurgensen, APRN CNP | |
|
1445 N Main St, Spearfish, SD 57783-1427 | |
| (605) 644-4244 | |
| (605) 644-4224 |
| Full Name | Kristina Danielle Jurgensen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1445 N Main St, Spearfish, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376240739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP002680 (South Dakota) | Primary |
| Entity Name | Monument Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588185268 PECOS PAC ID: 5991616427 Enrollment ID: O20031111000854 |
News Archive
New York Attorney General Eric Schneiderman says his office has reached settlements with eight health insurance companies that require them to ensure the accuracy of provider directories on their websites. The attorney general's office says the companies will remove names of doctors and other providers who no longer participate and correct listing errors for others.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
A large national study of dentists conducted by the National Dental Practice-Based Research Network has found that only 47 percent of dentists always use a dental dam during root canal treatment, with an additional 17 percent using it 90-99 percent of the time, according to a recent scientific publication in BMJ Open.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).
› Verified 6 days ago
| Entity Name | Rapid City Medical Center Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558373845 PECOS PAC ID: 5890691075 Enrollment ID: O20031209000567 |
News Archive
New York Attorney General Eric Schneiderman says his office has reached settlements with eight health insurance companies that require them to ensure the accuracy of provider directories on their websites. The attorney general's office says the companies will remove names of doctors and other providers who no longer participate and correct listing errors for others.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
A large national study of dentists conducted by the National Dental Practice-Based Research Network has found that only 47 percent of dentists always use a dental dam during root canal treatment, with an additional 17 percent using it 90-99 percent of the time, according to a recent scientific publication in BMJ Open.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristina Danielle Jurgensen, APRN CNP Po Box 204, Spearfish, SD 57783-0204 Ph: (605) 759-3801 | Kristina Danielle Jurgensen, APRN CNP 1445 N Main St, Spearfish, SD 57783-1427 Ph: (605) 644-4244 |
News Archive
New York Attorney General Eric Schneiderman says his office has reached settlements with eight health insurance companies that require them to ensure the accuracy of provider directories on their websites. The attorney general's office says the companies will remove names of doctors and other providers who no longer participate and correct listing errors for others.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
A large national study of dentists conducted by the National Dental Practice-Based Research Network has found that only 47 percent of dentists always use a dental dam during root canal treatment, with an additional 17 percent using it 90-99 percent of the time, according to a recent scientific publication in BMJ Open.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).
› Verified 6 days ago
Katy Jean Jones, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1445 North Ave, Spearfish, SD 57783 Phone: 605-644-4170 | |
Dr. Travis Hugh Williamson, DNP, CNP, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 115 N 7th St Ste 6, Spearfish, SD 57783 Phone: 605-645-0100 Fax: 605-717-1009 | |
Rachelle Cockrell, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1420 N 10th St, Spearfish, SD 57783 Phone: 605-717-8595 | |
Christina Dawn Coffield, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 623 Dahl Rd, Spearfish, SD 57783 Phone: 605-642-2777 | |
Kayla B Hatten, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1445 North Ave, Spearfish, SD 57783 Phone: 605-644-4170 | |
Janesa Ryan, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1445 North Ave, Spearfish, SD 57783 Phone: 605-644-4170 | |
Jacobb Howard Schumacher, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1420 N 10th St, Spearfish, SD 57783 Phone: 605-717-8595 |